AstraZeneca unveils $50bn US investment as pharma tariff threat looms – business live - short news
Rolling coverage of the latest economic and financial news
Here’s where AstraZeneca plans to spend its $50bn:
Expansion of its R&D facility in Gaithersburg, Maryland
State-of-the-art R&D centre in Kendall Square, Cambridge, Massachusetts
Next-generation manufacturing facilities for cell therapy in Rockville, Maryland and Tarzana, California
Continuous manufacturing expansion in Mount Vernon, Indiana
Specialty manufacturing expansion in Coppell,..
source: The Guardian - 22.07.2025